HomeNWBO • OTCMKTS
add
Northwest Biotherapeutics Inc
Previous close
$0.28
Day range
$0.27 - $0.29
Year range
$0.24 - $0.88
Market cap
352.26M USD
Avg Volume
2.10M
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 357.00K | -12.07% |
Operating expense | 7.03M | -0.03% |
Net income | -19.37M | 17.63% |
Net profit margin | -5.43K | 6.33% |
Earnings per share | — | — |
EBITDA | -14.36M | -7.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.94M | -51.80% |
Total assets | 29.32M | -6.89% |
Total liabilities | 93.56M | 35.70% |
Total equity | -64.24M | — |
Shares outstanding | 1.30B | — |
Price to book | -4.72 | — |
Return on assets | -128.60% | — |
Return on capital | 916.47% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -19.37M | 17.63% |
Cash from operations | -8.23M | 40.85% |
Cash from investing | -176.00K | 59.73% |
Cash from financing | 11.62M | -32.14% |
Net change in cash | 58.00K | -98.76% |
Free cash flow | -3.99M | 54.34% |
